Semaglutide weight Loss

Semaglutide (Wegovy, Ozempic, Rybelsus) is a Food and Drug Administration (FDA) weight loss medication that is administered once weekly to help you with long-term weight management. Once-weekly Semaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1) that stimulates glucose-dependent insulin secretion.

• GLP-1 also inhibits glucagon release and gastric emptying.
• GLP-1 receptor agonists bind to the GLP-1 receptor and stimulate glucose-dependent insulin release from the pancreatic islets.

These key elements lead to sustainable weight loss at a faster rate than what could be achieved naturally.

.

In many patients, weight gain affects their health and confidence. This weight loss medication is best suited for adults with a BMI >30 or a BMI>27 with comorbidities (high blood pressure, diabetes, high cholesterol).

You should avoid Semaglutide if you are already taking Semaglutide-containing medications, taking certain medications, such as steriods/corticosteroids, insulin.

• decreases food intake
• suppresses appetite
• decreases hunger cravings
• reduces fat mass in the body

long-term weight loss medication

This medication is administered subcutaneously in the thigh, upper arm, or abdomen once a week. Our patients have the option of receiving injections in our office or taking home vials of the medication to take at home on a weekly basis.

• Patients with a personal or family history of medullary thyroid carcinoma.
• Patients with a rare condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• Patients with a history of severe allergic reactions to Semaglutide or its ingredients.
• Patients who experience inflammation of the pancreas (pancreatitis), gallbladder problems (including gallstones), symptoms of pancreatitis or gallstones, low blood sugar, acute kidney injury, diabetic retinopathy (damage to the eye’s retina), increased heart rate, and suicidal behavior or thinking.
• You are pregnant.
• If you take Semaglutide with insulin or an insulin secretagogue (e.g. a sulfonylurea), blood glucose should be monitored, and a dose reduction in the insulin or the sulfonylurea may be necessary to avoid hypoglycemia.

Known risks or side effects associated with Semaglutide include:

• Nausea
• Diarrhea
• Abdominal pain
• Vomiting
• Constipation
• Headache
• Fatigue
• Dizziness
• Low blood sugar

If you experience any of these side effects, they are mild and resolved on their own within a few weeks and please contact us. Rare cases of angioedema and anaphylaxis have been reported with Semaglutide. Please go to the nearest emergency room or call 911.